<?xml version="1.0" encoding="UTF-8"?>
<ref id="B185">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Shanmugam</surname>
    <given-names>M. K.</given-names>
   </name>
   <name>
    <surname>Ahn</surname>
    <given-names>K. S.</given-names>
   </name>
   <name>
    <surname>Hsu</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Woo</surname>
    <given-names>C. C.</given-names>
   </name>
   <name>
    <surname>Yuan</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Tan</surname>
    <given-names>K. H. B.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2018a</year>). 
  <article-title>Thymoquinone inhibits bone metastasis of breast cancer cells through abrogation of the CXCR4 signaling 
   <italic>Axis</italic>
  </article-title>. 
  <source>Front. Pharmacol.</source>
  <volume>9</volume>, 
  <fpage>1294</fpage>. 
  <pub-id pub-id-type="doi">10.3389/fphar.2018.01294</pub-id>
  <pub-id pub-id-type="pmid">30564115</pub-id>
 </mixed-citation>
</ref>
